Literature DB >> 11487520

A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonists.

R B Barlow1, S M Bond, C Grant, D S McQueen, Z Yaqoob.   

Abstract

If one drug, B, antagonizes another, A, by producing the opposite physiological effect, the antagonist concentration-effect curves should be affected by the recording system, which limits the range of agonist responses. With pieces of isolated guinea-pig ileum taken from adjacent parts of the same animal, one recorded isotonically, the other isometrically with the same load, the isotonic IC(50) values for (-)isoprenaline opposing carbachol or histamine were lower than the isometric values (P<0.01) but there was a significant correlation between them (P<0.01): the isotonic curves were steeper (P<0.01) and there were wider shifts in IC(50) before increasing the agonist reduced the maximum relaxation. In similar experiments with pieces of rat uterus in oestrus from the same animal, the concentration-effect curves for carbachol opposed by increasing concentrations of (-)isoprenaline or (-)adrenaline had slightly lower EC(50) values with isometric recording but there was a significant correlation (P<0.01) with isotonic values. The antagonist effect (ratio of the EC(50) relative to that for the control) was higher with isotonic recording (P<0.01 for (-)isoprenaline, P<0.025 for (-)adrenaline) and all (27) curves were steeper than the corresponding isometric curve (P<0.001). The influence of the method of recording on the results is expected from the narrower operational window and smaller upper limit to relaxation with isotonic recording. A way of obtaining measurements of IC(50) against a standard agonist effect is suggested in an Appendix.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487520      PMCID: PMC1572875          DOI: 10.1038/sj.bjp.0704169

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Affinity, intrinsic activity and drug interactions.

Authors:  E J ARIENS; J M VAN ROSSUM; A M SIMONIS
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

2.  Use of an antagonist for estimating the degree of agonist stimulation during physiological release.

Authors:  R B Barlow
Journal:  Trends Pharmacol Sci       Date:  1995-08       Impact factor: 14.819

3.  Quantification of the characteristics of antagonists exhibiting both competitive antagonism and functional interaction.

Authors:  I E Hughes; D Mackay
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

4.  The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism.

Authors:  F G van den Brink
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

5.  The model of functional interaction. II. Experimental verification of a new model: the antagonism of beta-adrenoceptor stimulants and other agonists.

Authors:  F G van den Brink
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

6.  An analysis of functional antagonism and synergism.

Authors:  D Mackay
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

7.  Analysis of the effects of alpha 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery.

Authors:  P H Van der Graaf; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Extended concentration-response curves used to reflect full agonist efficacies and receptor occupancy-response coupling ranges.

Authors:  M J Lew
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

9.  A test of the null equation for functional antagonism.

Authors:  J Emmerson; D Mackay
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

10.  Mechanisms of melatonin-induced vasoconstriction in the rat tail artery: a paradigm of weak vasoconstriction.

Authors:  M J Lew; S Flanders
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

View more
  1 in total

1.  Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.

Authors:  R Makwana; A Molleman; M E Parsons
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.